AMBER LONG: Open Payments
NPI 1902858095 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 43 payments from 10 companies in 2025. Trend: 2023 $1,416 · 2024 $1,065 · 2025 $976
Food & beverage: $824Education: $152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $206 |
| Novartis Pharmaceuticals Corporation | 6 | $154 |
| Janssen Biotech, Inc. | 5 | $149 |
| LEO Pharma Inc. | 5 | $135 |
| Sun Pharmaceutical Industries Inc. | 1 | $85 |
| UCB, Inc. | 3 | $80 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 3 | $46 |
| Organon LLC | 5 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
Products named: TREMFYA, ADBRY, Rhapsido, Bimzelx, RINVOQ, Cabtreo, SKYRIZI, BOTOX.
Industry payments across CO — which companies pay providers there.
